|
Sign In to gain access to subscriptions and/or personal tools.
|
Vascular Medicine, Vol. 4, No. 1,
15-21 (1999)
DOI: 10.1177/1358836X9900400103
Quantitative and qualitative progression of peripheral arterial disease by non-invasive testing
Cameron E Bird
Department of Family and Preventive Medicine, University of California, San Diego, La Jolla, CA, USA
Michael H Criqui
Department of Family and Preventive Medicine, University of California, San Diego, La Jolla, CA, USA
Arnost Fronek
Department of Surgery and Bio-Engineering, University of California, San Diego, La Jolla, CA, USA
Julie O Denenberg
Department of Family and Preventive Medicine, University of California, San Diego, La Jolla, CA, USA
Melville R Klauber
Department of Family and Preventive Medicine, University of California, San Diego, La Jolla, CA, USA
Robert D Langer
Department of Family and Preventive Medicine, University of California, San Diego, La Jolla, CA, USA
There is little information on the progression of peripheral arterial disease (PAD) over time. A series of 508 patients with a prior examination for PAD were contacted and brought in for follow-up to evaluate the natural history of PAD. A total of 85 patients were excluded because they had interventions in both limbs prior to their return visit. Progression was assessed in the remaining 423 patients for a total of 755 limbs, both quantitatively and qualitatively using six categories of PAD severity. There was a modest overall categorical progression of disease: 228 limbs (30.2%) displayed categorical progression, while 172 limbs (22.8%) improved over a 4.6-year average follow-up. Through analysis of quantitative change, it was determined that more quantitative progression occurred than was evident from categorical progression. Two of the three non-invasive tests employed, the ankle/brachial index (ABI) and posterior tibial peak forward flow velocity (peak PT), showed statistically significant progression during follow-up: mean ABI change =-0.019, 95% confidence interval (CI) =-0.031 to -0.007; mean peak PT change =-2.32 cm/s, 95% CI =-3.20 to -1.44. The toe/brachial index (TBI) also suggested progression: mean change =-0.013, but the 95% CI included no change. Standard scores (sum of the Z-scores for ABI, peak PT and TBI) were calculated. The standard score progressed approximately 0.34 units (standard deviations), p-value,0.001, over 4.6 years; or about 0.07 standard deviations per year. There were independent and statistically significant (p, 0.05) associations between the rate of PAD progression (standard score change) and age, diabetes, classic (`Rose') intermittent claudication, moderate to severe PAD in the same limb, moderate to severe PAD in the contralateral limb and future therapeutic intervention. There were independent and suggestive associations (0.05, p-value, 0.15) between PAD progression and pain at rest, mild PAD in the same limb, and mild PAD in the contralateral limb. PAD progression was not associated with gender, atypical claudication, or amputation status.
Thus, in this cohort of PAD patients, PAD on average progressed significantly over 4.6 years. This progression was independently related to age, diabetes and several markers of disease severity.
Key Words: ankle/brachial index • diabetes mellitus • disease progression • intermittent claudication • non-invasive diagnosis • peripheral vascular disease
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
L. M. Steffen, D. A. Duprez, J. L. Boucher, A. G. Ershow, and A. T. Hirsch
Management of Peripheral Arterial Disease
Diabetes Spectr,
July 1, 2008;
21(3):
171 - 177.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Shadman, M. A. Allison, and M. H. Criqui
Glomerular Filtration Rate and N-Terminal Pro-Brain Natriuretic Peptide as Predictors of Cardiovascular Mortality in Vascular Patients
J. Am. Coll. Cardiol.,
June 5, 2007;
49(22):
2172 - 2181.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. Aboyans, M. H. Criqui, M. M. McDermott, M. A. Allison, J. O. Denenberg, R. Shadman, and A. Fronek
The Vital Prognosis of Subclavian Stenosis
J. Am. Coll. Cardiol.,
April 10, 2007;
49(14):
1540 - 1545.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Montorsi, P. M. Ravagnani, S. Galli, F. Rotatori, F. Veglia, A. Briganti, A. Salonia, F. Deho, P. Rigatti, F. Montorsi, et al.
Association between erectile dysfunction and coronary artery disease. Role of coronary clinical presentation and extent of coronary vessels involvement: the COBRA trial
Eur. Heart J.,
November 2, 2006;
27(22):
2632 - 2639.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. Aboyans, M. H. Criqui, J. O. Denenberg, J. D. Knoke, P. M Ridker, and A. Fronek
Risk Factors for Progression of Peripheral Arterial Disease in Large and Small Vessels
Circulation,
June 6, 2006;
113(22):
2623 - 2629.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. Tzoulaki, G. D. Murray, J. F. Price, F. B. Smith, A. J. Lee, A. Rumley, G. D. O. Lowe, and F. G. R. Fowkes
Hemostatic Factors, Inflammatory Markers, and Progressive Peripheral Atherosclerosis: The Edinburgh Artery Study
Am. J. Epidemiol.,
February 15, 2006;
163(4):
334 - 341.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. A. Beckman, C. O. Higgins, and M. Gerhard-Herman
Automated Oscillometric Determination of the Ankle-Brachial Index Provides Accuracy Necessary for Office Practice
Hypertension,
January 1, 2006;
47(1):
35 - 38.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. C. Wang, M. H. Criqui, J. O. Denenberg, M. M. McDermott, B. A. Golomb, and A. Fronek
Exertional Leg Pain in Patients With and Without Peripheral Arterial Disease
Circulation,
November 29, 2005;
112(22):
3501 - 3508.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Kennedy, C. Solomon, T. A. Manolio, M. H. Criqui, A. B. Newman, J. F. Polak, G. L. Burke, P. Enright, and M. Cushman
Risk Factors for Declining Ankle-Brachial Index in Men and Women 65 Years or Older: The Cardiovascular Health Study
Arch Intern Med,
September 12, 2005;
165(16):
1896 - 1902.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. Tzoulaki, G. D. Murray, A. J. Lee, A. Rumley, G. D.O. Lowe, and F. G. R. Fowkes
C-Reactive Protein, Interleukin-6, and Soluble Adhesion Molecules as Predictors of Progressive Peripheral Atherosclerosis in the General Population: Edinburgh Artery Study
Circulation,
August 16, 2005;
112(7):
976 - 983.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A.J. Lee, J.F. Price, M.J. Russell, F.B. Smith, M.C.W. van Wijk, and F.G.R. Fowkes
Improved Prediction of Fatal Myocardial Infarction Using the Ankle Brachial Index in Addition to Conventional Risk Factors: The Edinburgh Artery Study
Circulation,
November 9, 2004;
110(19):
3075 - 3080.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Shadman, M. H. Criqui, W. P. Bundens, A. Fronek, J. O. Denenberg, A. C. Gamst, and M. M. McDermott
Subclavian artery stenosis: Prevalence, risk factors, and association with cardiovascular diseases
J. Am. Coll. Cardiol.,
August 4, 2004;
44(3):
618 - 623.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. C. Pasternak, M. H. Criqui, E. J. Benjamin, F. G. R. Fowkes, E. M. Isselbacher, P. A. McCullough, P. A. Wolf, and Z.-J. Zheng
Atherosclerotic Vascular Disease Conference: Writing Group I: Epidemiology
Circulation,
June 1, 2004;
109(21):
2605 - 2612.
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. R. Mohler III
Peripheral Arterial Disease: Identification and Implications
Arch Intern Med,
October 27, 2003;
163(19):
2306 - 2314.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. I. Adler, R. J. Stevens, A. Neil, I. M. Stratton, A. J. M. Boulton, and R. R. Holman
UKPDS 59: Hyperglycemia and Other Potentially Modifiable Risk Factors for Peripheral Vascular Disease in Type 2 Diabetes
Diabetes Care,
May 1, 2002;
25(5):
894 - 899.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. C. Dolan, K. Liu, M. H. Criqui, P. Greenland, J. M. Guralnik, C. Chan, J. R. Schneider, A. L. Mandapat, G. Martin, and M. M. McDermott
Peripheral Artery Disease, Diabetes, and Reduced Lower Extremity Functioning
Diabetes Care,
January 1, 2002;
25(1):
113 - 120.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
